tris(2-aminoethyl)amine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghoshal, K; Hsu, SH; Jacob, ST; Lee, LJ; Lee, RJ; Mao, Y; Teng, L; Terp, MC; Wang, F; Wang, X; Wu, Y; Xue, W; Yu, B; Zhou, C | 1 |
| Higashiyama, S; Kawase, M; Kurikawa, N; Miura, N; Mizoguchi, T; Ozawa, C; Shiomi, T; Yagi, K | 1 |
2 other study(ies) available for tris(2-aminoethyl)amine and Liver Neoplasms
| Article | Year |
|---|---|
Lipid nanoparticles for hepatic delivery of small interfering RNA.
Topics: Animals; Cell Line; Colloids; Down-Regulation; Drug Delivery Systems; Ethylenediamines; Fatty Acids, Unsaturated; Humans; Lipids; Liver; Liver Neoplasms; Mice; Mice, Inbred ICR; Nanoparticles; RNA Stability; RNA, Small Interfering; Tissue Distribution | 2012 |
Immobilization of ligand-modified polyamidoamine dendrimer for cultivation of hepatoma cells.
Topics: Animals; Azirines; Benzoates; Cell Adhesion; Cell Division; Cell Membrane; Cell Survival; Cells, Immobilized; Chelating Agents; Cross-Linking Reagents; Dendrimers; Ethylenediamines; Fructose; Ligands; Liver Neoplasms; Liver Neoplasms, Experimental; Liver, Artificial; Polyamines; Polystyrenes; Rats; Succinimides; Tumor Cells, Cultured; Urea | 2000 |